News | Proton Therapy | October 17, 2017

IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy

Technology marks progress toward successful treatment of moving tumor targets

IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy

October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful completion of the first gated treatment at the Proton Therapy Center in Trento, Italy.
 
For the first time, the clinical team in Trento completed a gated treatment for a patient affected by unresectable thymoma. They delivered active scanning proton therapy by synchronizing the proton beams with the patient respiratory cycle. This technique was performed through real-time tracking of the patient’s respiratory motion, without any use of physical marker (Vision RT). The technology of Vision RT tracks the patient’s 3-D surface in real time, which enhances patient comfort and safety, and improves the efficiency of the radiation therapy by the clinical team.

GateCT was used to track the patient’s breathing during the computed tomography (CT) scanning and thereby enabling 4-D CT acquisition and reconstruction. The evaluation of the interplay effect for a free-breathing treatment is performed using the different phases of the 4-D CT.

During treatment delivery, accurate gating was ensured, allowing automatic beam hold when the breathing amplitude was higher than the one measured during the 4DCT scan.
 
Maurizio Amichetti, M.D., clinical director of the Proton Therapy Center, commented: “This is a big step towards the full implementation of moving-target treatments with pencil beam scanning in our center. The moving-target project team leaders, Dr. Francesco Dionisi and Dr. Francesco Fracchiolla reported impressive results in terms of treatment feasibility and efficacy. We are really proud to improve every day with the goal of translating research projects in a clinical benefit for our patients.”

For more information: www.iba-worldwide.com

Related Content

GE Healthcare unveiled Revolution Ascend with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate and simplify time-consuming tasks to increase operational efficiency and free up time for clinicians to deliver more personalized care to more patients.
News | Computed Tomography (CT) | September 27, 2021
September 27, 2021 — GE Heal
Zebra Medical Vision now offers artificial intelligence (A) medical imaging analytics for its cardiac solution HealthCCSng, which enables the quantification of the coronary artery calcium (CAC) on CT scans as an incidental finding.
News | Artificial Intelligence | September 27, 2021
September 27, 2021 — Zebra Medical Vision, the deep-learning medical imaging analytics company, announces its eighth
Volpara Health, a global health technology software leader providing an integrated platform for the delivery of personalized breast and lung care, further expanded its footprint in the US lung screening market with a strategic relationship with Seattle-based lung AI company RevealDx.

Getty Images

News | Lung Imaging | September 27, 2021
September 27, 2021 — Volpara Health, a global health technology software leader providing an integrated platform for
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian

News | Radiation Therapy | September 24, 2021
September 24, 2021 — The ...
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021
September 23, 2021 — The National Cancer Institute announced tha
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

Getty Images

News | Lung Imaging | September 15, 2021
September 15, 2021 — Revised guidelines for...
To get more flexibility and cost savings from storage, healthcare organizations are increasing their investments in the cloud
Feature | Information Technology | September 15, 2021 | By Kumar Goswami
Healthcare organizations today are storing petabytes of medical imaging data — lab slides,...